| Literature DB >> 30544947 |
Guojun Yan1, Qian Du2, Xuchao Wei3, Jackelyn Miozzi4, Chen Kang5, Jinnv Wang6, Xinxin Han7, Jinhuo Pan8, Hui Xie9, Jun Chen10, Weihua Zhang11.
Abstract
Objective: We summarized the progress of the xCELLigence real-time cell analysis (RTCA) technology application in recent years for the sake of enriching and developing the application of RTCA in the field of Chinese medicine. Background: The RTCA system is an established electronic cellular biosensor. This system uses micro-electronic biosensor technology that is confirmed for real-time, label-free, dynamic and non-offensive monitoring of cell viability, migration, growth, spreading, and proliferation.Entities:
Keywords: RTCA; application progress; pharmaceutical evaluation; traditional Chinese medicine
Mesh:
Substances:
Year: 2018 PMID: 30544947 PMCID: PMC6321149 DOI: 10.3390/molecules23123280
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Schematic diagram for the mechanism of Real-Time Cell-based Assay.
Figure 2CI-t curve of MCF-7 cell line based on different concentration of Panax notoginseng extractive (curve from up to bottom show the concentration as con, 0.17, 0.28, 0.47, 0.78, 1.3, 2.16, 3.6 mg/mL).
Figure 3Effect of different sample concentrations on real-time cell analyzer curves generated with LX2 cells. Effect of 2 mg/mL (red line), 1.5 mg/mL (green line), 1.0 mg/mL (blue line), 0.78 mg/mL (pink line), 0.39 mg/mL (turquoise line), 0.19 mg/mL (purple line), CON (brown line, control group without treatment).